>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
三氧化二砷抗肝癌血管新生作用
作者:刘琳1 秦叔逵2 陈宝安1 赵伟3 李苏宜1 华海清2 王南瑶1 杨爱珍2 陈惠英2 
单位:1.东南大学附属中大医院肿瘤科,江苏南京,210009; 2.中国人民解放军第八一医院全军肿瘤中心,江苏南京,210002; 3.东南大学医学院附属南京第二医院,江苏,南京,210003
关键词:三氧化二砷 肝癌 血管生成 
分类号:R735.7, R730.53
出版年·卷·期(页码):2008·27·第五期(330-335)
摘要:

目的:探讨三氧化二砷(As2O3)注射液抗肝癌血管新生的作用及其相关机制.方法:采用MTT法、透射电镜观察、免疫组化、鸡胚尿囊膜(CAM)血管形成实验等方法,观察As2O3注射液对人肝癌细胞株SMMC-7721和人脐静脉内皮细胞ECV304生长、超微结构、血管内皮生长因子(VEGF)和表皮生长因子受体(EGFR)蛋白表达以及对CAM血管形成的影响.结果:As2O3能显著抑制人肝癌细胞SMMC-7721和人脐静脉内皮细胞ECV304生长,用药后诱导其出现了典型的细胞凋亡超微结构改变;As2O3对SMMC-7721细胞和ECV304细胞VEGF、 EGFR的表达均有抑制作用;As2O3能抑制CAM血管形成.结论:As2O3注射液具有显著抗肝癌血管新生作用,其机制与抑制血管内皮细胞生长、诱导血管内皮细胞凋亡、调控肿瘤血管新生相关因子VEGF和EGFR的表达密切相关.

Objective To explore the effects and mechanisms of the anti-angiogenesis of arsenic trioxide(As2O3) injection on hepatocarcinoma.Methods As2O3’s action on the cell growth,ultrastructure and the expression of vascular endothelial growth factor(VEGF) and epidermal growth factor receptor(EGFR)of human hepatocarcinoma cell line SMMC-7721 and human umbilical vein cell line ECV304 was observed by MTT assay,transmission electronmicroscopy detection and immunohistochemical staining.The inhibitory effect of As2O3 on angiogenesis was investigated by the method of chick chorioallantoic membrane(CAM).Results As2O3 could obviously inhibit the growth of SMMC-7721 and ECV304,induce them appearing typical apoptosis ultrastructure changes and down-regulate the expression of VEGF and EGFR.As2O3 could also inhibit the angiogenesis in the CAM.Conclusions As2O3 injection can significantly inhibit tumor angiogenesis,which is closely related to suppressing the growth of vascular endothelial cell,inducing the apoptosis of vascular endothelial cell and down-regulating the expression of VEGF and EGFR.

参考文献:

[1] FOLKMAN J. Tumorangiogenesis:therapeutic implications. 1971. doi:10.1056/NEJM197111182852108
[2] CHA C, DEMATTEO R P. Molecular mechanisms in hepatocellular carcinoma development. 2005(1). doi:10.1016/j.bpg.2004.11.005
[3] SANQRO B, MAZZOLLINI G, PRIETO J. Future therapies for hepatocellular carcinoma. 2005(5). doi:10.1097/00042737-200505000-00007
[4] 秦叔逵, 陈洪, 陈惠英. 三氧化二砷诱导人肝癌细胞株凋亡的初步研究, 1998(2)
[5] 秦叔逵. 三氧化二砷治疗原发性肝胆癌的研究进展. 肿瘤学杂志2001(2). doi:10.3969/j.issn.1671-170X.2001.02.020
[6] 钱军, 秦叔逵, 何泽明. 三氧化二砷注射液治疗中晚期原发性肝胆癌的临床研究. 中华肿瘤杂志2001(6)
[7] MER J. Ancient remedy perform new tricks. 1996(5275). doi:10.1126/science.273.5275.578
[8] 马军. 急性早幼粒细胞白血病的"靶向"治疗. 中国肿瘤1999(2)
[9] CHEN G Q, SHI X G, TANG W. Use of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL):I.As2O3 exertsdose-dependent dual effects on APL cells, 1997(9)
[10] 刘琳, 赵伟, 秦叔逵. 三氧化二砷抗裸鼠人结肠癌移植瘤作用及其机制的研究. 中国肿瘤临床2005(18). doi:10.3969/j.issn.1000-8179.2005.18.016
[11] 刘琳, 秦叔逵, 王锦鸿. 三氧化二砷选择性诱导人肝癌细胞凋亡及相关基因的实验研究. 中华肝脏病杂志2000(6)
[12] 苏颖, 陈增, 林可焴. 三氧化二砷抑制肝癌细胞端粒酶表达及诱导细胞凋亡作用. 世界华人消化杂志2003(3). doi:10.3969/j.issn.1009-3079.2003.03.004
[13] JAIN R K. Tumor angiogenesis and accessibility:role of vascular endothelial growth factor, 2002(6 suppl16)
[14] TABERNER O. The role of VEGF and EGFR inhibition:implications for combining anti-VEGF and anti-EGFR agents. 2007(3). doi:10.1158/1541-7786.MCR-06-0404
[15] KARPANENT T, EGEBLAD N, KARKAINEN M J. Vascular endothelian growth factors promotes tumor lymphangiogensis and intralympatic tumor growth. 2001(5)
[16] 华海清, 秦叔逵, 王锦鸿. 三氧化二砷抗肿瘤血管形成研究. 世界华人消化杂志2004(1). doi:10.3969/j.issn.1009-3079.2004.01.008

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 187077 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364